In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Stephan Rosenkranz
Speaker
Stephan Rosenkranz
Stephan Rosenkranz Stephan Rosenkranz

Heart Center at the University of Cologne, Cologne (Germany)

Specialities : Chronic Heart Failure , Pulmonary Circulation-Pulmonary Embolism-Right Heart Failure, Basic Science, Pharmacology and Pharmacotherapy

Stephan Rosenkranz, MD, is an interventional cardiologist, and serves as the Head of the Pulmonary Hypertension (PH) Center at the University of Cologne, Germany, and leads the Cologne Cardiovascular Research Center (CCRC). He graduated from Justus Liebig University Giessen, Germany, before becoming a physician and research fellow at the University of Cologne. He also undertook a post-doctoral fellowship at Harvard Medical School, USA, before returning to Cologne. He is currently the Chair of the Working Group “Pulmonary Circulation and Right Ventricular Function” of the European Society of Cardiology. His research interests include cardiopulmonary interaction and right ventricular function in left heart disease, and signal transduction and biological importance of tyrosine kinases and stress signalling in cardiovascular disease. He has been involved in numerous clinical trials in the fields of atherosclerosis, heart failure and PH, and received numerous scientific awards.

25 presentations from this speaker

Contemporary management of pulmonary hypertension

Event : ESC Congress 2019

  • Session : Pulmonary hypertension, pulmonary embolism and adult congenital heart disease: Essential Update
  • Speaker : S Rosenkranz (Koln,DE)

Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - PRO

Event : ESC Congress 2019

  • Session : Controversies in the management of pulmonary hypertension and venous thromboembolism
  • Speaker : S Rosenkranz (Koln,DE)

Telemedicine-based invasive monitoring in heart failure: challenges and opportunities

Event : ESC Congress 2019

  • Session : Telemedicine in heart failure management – The minimum, the optimum, and the unnecessary
  • Speaker : S Rosenkranz (Koln,DE)

Acute right ventricular failure linked to common cardiovascular causes

Event : Heart Failure 2018

  • Session : Acute right ventricular failure
  • Speaker : S Rosenkranz (Koln,DE)

Assessment and management of pulmonary hypertension in mitral valve stenosis.

Event : ESC Congress 2018

  • Session : An update on the management of mitral valve stenosis
  • Speaker : S Rosenkranz (Koln,DE)
  • Joint with the Interamerican Society of Cardiology

Closing remarks - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2.

Event : ESC Congress 2018

  • Session : Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by Actelion Pharmaceuticals Ltd

Haemodynamic characterization of PH due to heart failure.

Event : ESC Congress 2018

  • Session : Pulmonary hypertension due to left heart disease: look RIGHT !
  • Speaker : S Rosenkranz (Koln,DE)

Panel discussion - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2.

Event : ESC Congress 2018

  • Session : Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2
  • Speaker : S Rosenkranz (Koln,DE), A Torbicki (Otwock,PL), V McLaughlin (Ann Arbor,US), F Bauer (Rouen Cedex,FR)
  • Sponsored by Actelion Pharmaceuticals Ltd

Pulmonary hypertension in the patient with heart failure: what are the options?

Event : ESC Congress 2018

  • Session : Double jeopardy - Pulmonary hypertension in high-risk situations
  • Speaker : S Rosenkranz (Koln,DE)

Right ventricular function in heart failure

Event : Heart Failure 2018

  • Session : Cardiopulmonary interactions: an update for a clinician
  • Speaker : S Rosenkranz (Koln,DE)

Wireless pulmonary artery pressure monitoring in HFpEF: guidance to effectively reduce decompensation.

Event : Heart Failure 2018

  • Session : Beat as One: united in the fight against heart failure - improving clinical outcomes and enhancing life
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by Abbott

A patient with low-risk pulmonary embolism: home treatment? Conclusion and take home message

Event : ESC Congress 2017

  • Session : Pulmonary embolism: dilemmas in practical management
  • Speaker : S Rosenkranz (Koln,DE)

The cardiologists' perspective on pulmonary hypertension.

Event : ESC Congress 2017

  • Session : The cardiologists' perspective on pulmonary hypertension - An interactive session
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by MSD

Triple combination – Who, when, how.

Event : ESC Congress 2017

  • Session : PAH – Triple combination in a timely manner
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by Actelion Pharmaceuticals Ltd

A patient with pulmonary arterial hypertension and cardiovascular risk factors - Clinical case

Event : ESC Congress 2016

  • Session : Pulmonary hypertension in the elderly: do the Guidelines always help?
  • Speaker : S Rosenkranz (Koln,DE)

Erroneous haemodynamic measurements

Event : ESC Congress 2016

  • Session : Hot topics in pulmonary hypertension
  • Speaker : S Rosenkranz (Koln,DE)

Introduction - Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 2).

Event : ESC Congress 2016

  • Session : Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 2)
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by Actelion Pharmaceuticals Ltd

Interactive patient case - Interim discussion.

Event : ESC Congress 2015

  • Session : Expect the unexpected in the pulmonary arterial hypertension clinic
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by Actelion Pharmaceuticals Ltd

Right ventricle adaptation.

Event : Heart Failure 2015

  • Session : Pulmonary hypertension: look left, look right !
  • Speaker : S Rosenkranz (Koln,DE)

Panel discussion - New horizons in PAH.

Event : ESC Congress 2014

  • Session : New horizons in pulmonary arterial hypertension – Addressing treatment initiation
  • Speaker : N Galie (Bologna,IT), M Humbert (Le Kremlin-Bicetre,FR), S Rosenkranz (Koln,DE)
  • Sponsored by Actelion Pharmaceuticals Ltd

Pathophysiology, classification and epidemiology.

Event : ESC Congress 2014

  • Session : Pulmonary hypertension in left heart disease: marker or target?
  • Speaker : S Rosenkranz (Koln,DE)

Presentation 3.

Event : ESC Congress 2014

  • Session : From treatment initiation to combination therapy
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by Actelion Pharmaceuticals Ltd

Translating early detection into better outcomes.

Event : ESC Congress 2014

  • Session : New horizons in pulmonary arterial hypertension – Addressing treatment initiation
  • Speaker : S Rosenkranz (Koln,DE)
  • Sponsored by Actelion Pharmaceuticals Ltd

Medical and interventional modalities.

Event : ESC Congress 2013

  • Session : The right ventricle in pulmonary arterial hypertension
  • Speaker : S Rosenkranz (Koln,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are